Chinese biopharma Hutchmed today announced that the New Drug Application (NDA) for the combination of Orpathys (savolitinib) ...

US pharma major AbbVie is to buy Capstan Therapeutics, a San Diego-based biotech advancing in vivo engineering of cells ...

US mRNA specialist Moderna today announced positive results from a Phase III efficacy study (P304) evaluating the relative ...

US biotech major Amgen today announced the Phase III FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus ...

US biopharma Alto Neuroscience, a firm focused on the development of novel precision medicines for neuropsychiatric disorders ...

The nontuberculous mycobacteria (NTM) market across the seven major markets (7MM: the USA, France, Germany, Italy, Span, the UK and Japan) is forecast to grow at a compound annual growth rate (CAGR) ...

US biotech major Amgen, a late comer to the growing obesity treatment space, released new data showing that its MariTide ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the US Food and Drug Administration ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...

Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

Rising use of innovative medicines and shifting spending patterns are reshaping the global pharmaceutical landscape, ...

German drugmaker Bayer (BAYN: DE) has renewed its partnership with China’s Tsinghua University for another three years, ...